The field of biomolecular interaction analysis has been revolutionised over the past decade with the development of biosensors that enable 'real-time' monitoring. Characteristically, these biosensing technologies combine mass sensitive transducers, biointerfacial chemistry and the specificity of a wide range of affinity ligands. Considerable development of these elements has occurred over the past few years and promises to create a new generation of portable biosensors. The majority of transducers for 'real-time' biomolecular interaction analysis are generic evanescent wave-based mass sensors or direct mass sensors. The construction of a suitable biointerface is a key component in biosensor design and has a critical influence on the biosensor's performance. Recent developments in these areas are presented with particular emphasis on commercially available technology.
No takes yet. Share an insight, caveat, or question.
Quinn et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: